Name | Dectrekumab |
---|
Description | Dectrekumab (QAX576) is a humanized monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research[1]. |
---|---|
Related Catalog | |
Target |
IL-13 |
References |
No Any Chemical & Physical Properties |